发明名称 |
PHARMACEUTICAL COMPOSITION COMPRISING SOLIFENACIN AMORPHOUS BODY |
摘要 |
PROBLEM TO BE SOLVED: To provide a pharmaceutical composition comprising a stable solifenacin amorphous body.SOLUTION: A pharmaceutical composition comprises an amorphous body of solifenacin or pharmaceutically acceptable salt thereof, and at least one selected from malic acid or pharmaceutically acceptable salt thereof and meglumine or pharmaceutically acceptable salt thereof. |
申请公布号 |
JP2015189677(A) |
申请公布日期 |
2015.11.02 |
申请号 |
JP20140066222 |
申请日期 |
2014.03.27 |
申请人 |
TEVA PHARMA JAPAN INC |
发明人 |
YAMASHITA TOMONORI;HORAGUCHI AKIHIKO |
分类号 |
A61K31/4725;A61K9/16;A61K9/20;A61K47/02;A61K47/08;A61K47/12;A61K47/18;A61K47/32;A61K47/36;A61K47/38;A61P1/00;A61P11/00;A61P11/02;A61P11/06;A61P13/10;A61P43/00 |
主分类号 |
A61K31/4725 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|